X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (109) 109
gastroenterology & hepatology (89) 89
gastroenterology and hepatology (74) 74
male (69) 69
adult (68) 68
female (68) 68
middle aged (54) 54
crohn's disease (47) 47
inflammatory bowel disease (42) 42
infliximab (35) 35
life sciences (34) 34
treatment outcome (33) 33
inflammatory-bowel-disease (31) 31
ulcerative colitis (31) 31
risk factors (26) 26
crohns-disease (25) 25
young adult (25) 25
crohn disease - drug therapy (24) 24
surgery (24) 24
abridged index medicus (22) 22
aged (22) 22
care and treatment (20) 20
medical research (20) 20
retrospective studies (20) 20
adolescent (19) 19
immunology (19) 19
patients (19) 19
medicine, experimental (18) 18
prospective studies (18) 18
maintenance therapy (17) 17
pharmacology & pharmacy (17) 17
therapy (17) 17
tumor necrosis factor-alpha - antagonists & inhibitors (17) 17
crohn disease - complications (16) 16
inflammatory bowel diseases (16) 16
tumor necrosis factor (16) 16
ulcerative-colitis (16) 16
analysis (15) 15
crohn disease - immunology (15) 15
immunosuppressive agents - therapeutic use (15) 15
chemical sciences (14) 14
human health and pathology (14) 14
organic chemistry (14) 14
[chim.orga]chemical sciences/organic chemistry (13) 13
endoscopy (13) 13
gastrointestinal diseases (13) 13
recurrence (13) 13
remission (13) 13
t cells (13) 13
crohn disease - surgery (12) 12
follow-up studies (12) 12
inflammatory bowel diseases - drug therapy (12) 12
management (12) 12
cancer (11) 11
expression (11) 11
inflammatory bowel diseases - complications (11) 11
intestine (11) 11
multivariate analysis (11) 11
prognosis (11) 11
tumors (11) 11
bacteriology (10) 10
biochemistry, molecular biology (10) 10
clinical trials (10) 10
colitis (10) 10
colonoscopy (10) 10
cytokines (10) 10
diagnosis (10) 10
hépatology and gastroenterology (10) 10
induction (10) 10
intestinal mucosa - pathology (10) 10
microbiology and parasitology (10) 10
molecular biology (10) 10
research (10) 10
severity of illness index (10) 10
time factors (10) 10
transplantation (10) 10
animals (9) 9
crohn disease - pathology (9) 9
intestinal mucosa - immunology (9) 9
outcomes (9) 9
[ chim.orga ] chemical sciences/organic chemistry (8) 8
antibodies (8) 8
antibodies, monoclonal - therapeutic use (8) 8
azathioprine (8) 8
cohort studies (8) 8
colectomy (8) 8
colitis, ulcerative - drug therapy (8) 8
consensus (8) 8
crohn’s disease (8) 8
evidence-based consensus (8) 8
ibd (8) 8
inflammation (8) 8
inflammatory bowel diseases - immunology (8) 8
mice (8) 8
mucosa (8) 8
oncology (8) 8
stem cells (8) 8
tumor necrosis factor-tnf (8) 8
[sdv.bbm.bm]life sciences [q-bio]/biochemistry, molecular biology/molecular biology (7) 7
[sdv.mp.bac]life sciences [q-bio]/microbiology and parasitology/bacteriology (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2012, Volume 380, Issue 9857, pp. 1909 - 1915
Journal Article
Autoimmunity Reviews, ISSN 1568-9972, 2014, Volume 13, Issue 1, pp. 15 - 19
Abstract Reports of autoimmune diseases, including psoriasis- and dermatitis-like skin reactions with anti-tumor necrosis factor-α (TNF-α), are increasing,... 
Allergy and Immunology | Autoimmunity | Anti-TNF | Paradoxical reactions | IBD | DEXTRAN SULFATE SODIUM | INDUCED PSORIASIS | SERIES | NEW-ONSET | MECHANISMS | ANTAGONIST THERAPY | IMMUNOLOGY | INTESTINAL INFLAMMATION | TUMOR-NECROSIS-FACTOR | INFLIXIMAB | BLOCKADE
Journal Article
Digestive and Liver Disease, ISSN 1590-8658, 2017, Volume 49, Issue 4, pp. 397 - 404
Journal Article
Gut, ISSN 0017-5749, 01/2018, Volume 67, Issue 1, pp. 53 - 53
ObjectiveThe efficacy of anti-tumour necrosis factors (anti-TNFs) in patients with Crohn's disease (CD) and symptomatic small bowel stricture (SSBS) is... 
FIBROSIS | ENTEROGRAPHY | ENTEROCLYSIS | TRIALS | THERAPY | INFLAMMATION | CONSENSUS | INDEX | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | LESIONS | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Intestinal Obstruction - diagnostic imaging | Adalimumab - adverse effects | Crohn Disease - complications | Adult | Female | Severity of Illness Index | Intestinal Obstruction - etiology | Crohn Disease - diagnostic imaging | Drug Administration Schedule | Treatment Outcome | Magnetic Resonance Imaging | Adalimumab - therapeutic use | Intestinal Obstruction - drug therapy | Adalimumab - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Crohn Disease - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Intestine, Small - diagnostic imaging | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Treatment outcome | Care and treatment | Dosage and administration | Crohn's disease | Adalimumab | Analysis | Corticoids | Nuclear magnetic resonance--NMR | Medical imaging | Clinical trials | Stenosis | Systematic review | Inflammation | Patients | Success | Abdomen | Crohns disease | Inflammatory bowel disease | Pain | Intestine | Surgery | Gangrene | Monoclonal antibodies | Tumor necrosis factor-TNF | Endoscopy | Cancer | Tumors | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | Immunology | Immunotherapy | ABDOMINAL MRI | CROHN'S DISEASE | Inflammatory Bowel Disease | 1506 | IBD CLINICAL
Journal Article
Journal Article
Journal Article